EGRP News Flash - February 22, 2013
Videocast Available for Cancer Treatment-Related Cardiotoxicity Meeting on March 20-21
Cancer treatment-related cardiotoxicity is the leading cause of treatment-associated mortality among survivors of pediatric and adolescent cancers, and one of the most common post-treatment issues among survivors of adult cancer.
The Epidemiology and Genomics Research Program (EGRP) invites online viewing of an upcoming NCI/NHLBI co-sponsored workshop, "Cancer Treatment-Related Cardiotoxicity: Understanding the Current State of Knowledge and Developing Future Research Priorities," on March 20 and 21, 2013.
This meeting is designed to bring together multiple disciplines in basic and clinical science to identify knowledge gaps and research priorities for this important area of cancer research. The meeting will feature representatives from the National Heart, Lung, and Blood Institute's (NHLBI) Division of Cardiovascular Sciences (DCVS), as well as from the National Cancer Institute's (NCI) Divisions of Cancer Control and Population Sciences (DCCPS) and Cancer Prevention (DCP).
The links below can be used to watch a live video stream of the meeting; however, the video will also be archived for later viewing.
For more information about the meeting, visit the Cancer Treatment-Related Cardiotoxicity Workshop page or contact EGRP's Nonniekaye F. Shelburne, C.R.N.P., M.S., A.O.C.N., Program Director, Clinical and Translational Epidemiology Branch.
Learn more about EGRP's interest in cancer treatment-related toxicity.